Probing in vivo dendritic cell functions by conditional cell ablation

Immunology and Cell Biology

Volumn 86, Issue 5, 2008, Pages 409-415

  Sapoznikov, Anita ^a   Jung, Steffen ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Cell ablation; Dendritic cell; Diphtheria toxin receptor; Plasmacytoid

Indexed keywords

DIFLUNISAL; L SELECTIN; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR;

B LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL FUNCTION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; DENDRITIC CELL; ENDOCYTOSIS; GENE MUTATION; HERPES SIMPLEX VIRUS; IMMUNE RESPONSE; IMMUNITY; IMMUNOSTIMULATION; IN VIVO STUDY; INFLUENZA VIRUS; LANGERHANS CELL; LYMPHOID TISSUE; MACROPHAGE; NONHUMAN; PLEIOTROPY; REVIEW; T LYMPHOCYTE; VIRUS IMMUNITY; VIRUS REPLICATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD11C; CELL DEATH; DENDRITIC CELLS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS;

EID: 46749154275     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2008.23     Document Type: Review

References (96)

1. Palmiter RD, Behringer RR, Quaife CJ, Maxwell F, Maxwell IH, Brinster RL. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 1987; 50: 435-443.
2. Chelur DS, Chalfie M. Targeted cell killing by reconstituted caspases. Proc Natl Acad Sci USA 2007; 104: 2283-2288.
3. Gu H, Zou YR, Rajewsky K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 1993; 73: 1155-1164.
4. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-1061.
5. + regulatory T cells. Nat Immunol 2003; 4: 330-336.
6. Zenke M, Hieronymus T. Towards an understanding of the transcription factor network of dendritic cell development. Trends Immunol 2006; 27: 140-145.
7. Woodruff MF, Anderson NA. Effect of lymphocyte depletion by thoracic duct fistula and administration of antilymphocytic serum on the survival of skin homografts in rats. Nature 1963; 200: 702.
8. Borrelli E, Heyman R, Hsi M, Evans RM. Targeting of an inducible toxic phenotype in animal cells. Proc Natl Acad Sci USA 1988; 85: 7572-7576.
9. Clark AJ, Iwobi M, Cui W, Crompton M, Harold G, Hobbs S et al. Selective cell ablation in transgenic mice expression E. coli nitroreductase. Gene Therapy 1997; 4: 101-110.
10. Saito M, Iwawaki T, Taya C, Yonekawa H, Noda M, Inui Y et al. Diphtheria toxin receptor-mediated conditional and targeted cell ablation in transgenic mice. Nat Biotechnol 2001; 19: 746-750.
11. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Sparwasser T et al. In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated antigens. Immunity 2002; 17: 211-220.
12. Holmes RK. Biology and molecular epidemiology of diphtheria toxin and the tox gene. J Infect Dis 2000; 181 (Suppl 1): S156-S167.
13. Naglich JG, Metherall JE, Russell DW, Eidels L. Expression cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like growth factor precursor. Cell 1992; 69: 1051-1061.
14. Pappenheimer Jr AM, Harper AA, Moynihan M, Brockes JP. Diphtheria toxin and related proteins: effect of route of injection on toxicity and the determination of cytotoxicity for various cultured cells. J Infect Dis 1982; 145: 94-102.
15. Yamaizumi M, Mekada E, Uchida T, Okada Y. One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell. Cell 1978; 15: 245-250.
16. Brocker T, Riedinger M, Karjalainen K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med 1997; 185: 541-550.
17. Lindquist RL, Shakhar G, Dudziak D, Wardemann H, Eisenreich T, Dustin ML et al. Visualizing dendritic cell networks in vivo. Nat Immunol 2004; 5: 1243-1250.
18. + dendritic cells during allergen challenge abrogates the characteristic features of asthma. J Exp Med 2005; 201: 981-991.
19. Landsman L, Jung S. Lung macrophages serve as obligatory intermediate between blood monocytes and alveolar macrophages. J Immunol 2007; 179: 3488-3494.
20. Probst HC, Tschannen K, Odermatt B, Schwendener R, Zinkernagel RM, Van Den Broek M. Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin Exp Immunol 2005; 141: 398-404.
21. + T cells in vivo. J Immunol 1995; 154: 5684-5693.
22. Beyer M, Wang H, Peters N, Doths S, Koerner-Rettberg C, Openshaw PJ et al. The beta2 integrin CD11c distinguishes a subset of cytotoxic pulmonary T cells with potent antiviral effects in vitro and in vivo. Respir Res 2005; 6: 70.
23. Hebel K, Griewank K, Inamine A, Chang HD, Muller-Hilke B, Fillatreau S et al. Plasma cell differentiation in T-independent type 2 immune responses is independent of CD11c(high) dendritic cells. Eur J Immunol 2006; 36: 2912-2919.
24. +, T cells by plasmacytoid dendritic cells. J Exp Med 2007; 204: 1923-1933.
25. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A. Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 2007; 26: 503-517.
26. + T cells. J Immunol 2005; 175: 6428-6435.
27. Zammit DJ, Cauley LS, Pham QM, Lefrancois L. Dendritic cells maximize the memory CD8 T cell response to infection. Immunity 2005; 22: 561-570.
28. Bennett CL, van Rijn E, Jung S, Inaba K, Steinman RM, Kapsenberg ML et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 2005; 169: 569-576.
29. Kissenpfennig A, Henri S, Dubois B, Laplace-Builhe C, Perrin P, Romani N et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005; 22: 643-654.
30. Bursch LS, Wang L, Igyarto B, Kissenpfennig A, Malissen B, Kaplan DH et al. Identification of a novel population of Langerin+ dendritic cells. J Exp Med 2007; 204: 3147-3156.
31. Ginhoux F, Collin MP, Bogunovic M, Abel M, Leboeuf M, Helft J et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J Exp Med 2007; 204: 3133-3146.
32. Poulin LF, Henri S, de Bovis B, Devilard E, Kissenpfennig A, Malissen B. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells. J Exp Med 2007; 204: 3119-3131.
33. - dendritic cells in the spleen. J Exp Med 2007; 204: 1653-1664.
34. Bennett CL, Clausen BE. DC ablation in mice: promises, pitfalls, and challenges. Trends Immunol 2007; 28: 525-531.
35. Probst HC, van den Broek M. Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells. J Immunol 2005; 174: 3920-3924.
36. Ciavarra RP, Stephens A, Nagy S, Sekellick M, Steel C. Evaluation of immunological paradigms in a virus model: are dendritic cells critical for antiviral immunity and viral clearance? J Immunol 2006; 177: 492-500.
37. Kassim SH, Rajasagi NK, Zhao X, Chervenak R, Jennings SR. In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses. J Virol 2006; 80: 3985-3993.
38. + T cell. Proc Natl Acad Sci USA 2007; 104: 6341-6346.
39. Scandella E, Fink K, Junt T, Senn BM, Lattmann E, Forster R et al. Dendritic cell-independent B cell activation during acute virus infection: a role for early CCR7-driven B-T helper cell collaboration. J Immunol 2007; 178: 1468-1476.
40. Neuenhahn M, Kerksiek KM, Nauerth M, Suhre MH, Schiemann M, Gebhardt FE et al. CD8alpha+ dendritic cells are required for efficient entry of Listeria monocytogenes into the spleen. Immunity 2006; 25: 619-630.
41. + T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection. J Immunol 2005; 175: 3268-3272.
42. Salazar-Gonzalez RM, Niess JH, Zammit DJ, Ravindran R, Srinivasan A, Maxwell JR et al. CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches. Immunity 2006; 24: 623-632.
43. Hapfelmeier S, Muller AJ, Stecher B, Kaiser P, Barthel M, Endt K et al. Microbe sampling by mucosal dendritic cells is a discrete, MyD88-independent stepin {Delta}invG S. Typhimurium colitis. J Exp Med 2008; 205: 437-450.
44. Engel D, Dobrindt U, Tittel A, Peters P, Maurer J, Gutgemann I et al. Tumor necrosis factor alpha- and inducible nitric oxide synthase-producing dendritic cells are rapidly recruited to the bladder in urinary tract infection but are dispensable for bacterial clearance. Infect Immun 2006; 74: 6100-6107.
45. Iezzi G, Frohlich A, Ernst B, Ampenberger F, Saeland S, Glaichenhaus N et al. Lymph node resident rather than skin-derived dendritic cells initiate specific T cell responses after Leishmania major infection. J Immunol 2006; 177: 1250-1256.
46. Schleicher U, Liese J, Knippertz I, Kurzmann C, Hesse A, Heit A et al. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J Exp Med 2007; 204: 893-906.
47. + cells impairs scrapie agent neuroinvasion from the intestine. J Immunol 2007; 179: 7758-7766.
48. Desai DD, Harbers SO, Flores M, Colonna L, Downie MP, Bergtold A et al. Fc gamma receptor IIB on dendritic cells enforces peripheral tolerance by inhibiting effector T cell responses. J Immunol 2007; 178: 6217-6226.
49. Harbers SO, Crocker A, Catalano G, D'Agati V, Jung S, Desai DD et al. Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance. J Clin Invest 2007; 117: 1361-1369.
50. Hagymasi AT, Slaiby AM, Mihalyo MA, Qui HZ, Zammit DJ, Lefrancois L et al. Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cells. J Immunol 2007; 179: 1524-1531.
51. Schmieg J, Yang G, Franck RW, Van Rooijen N, Tsuji M. Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion. Proc Natl Acad Sci USA 2005; 102: 1127-1132.
52. Shimizu K, Kurosawa Y, Taniguchi M, Steinman RM, Fujii S. Cross-presentation of glycolipid from tumor cells loaded with alpha-galactosylceramide leads to potent and long-lived T cell mediated immunity via dendritic cells. J Exp Med 2007; 204: 2641-2653.
53. KleinJan A, Willart M, van Rijt LS, Braunstahl GJ, Leman K, Jung S et al. An essential role for dendritic cells in human and experimental allergic rhinitis. J Allergy Clin Immunol 2006; 118: 1117-1125.
54. Sapoznikov A, Pewzner-Jung Y, Kalchenko V, Krauthgamer R, Shachar I, Jung S. Perivascular clusters of dendritic cells provide critical survival signals to B cells in bone marrow niches. Nat Immunol 2008; 9: 388-395.
55. Travis MA, Reizis B, Melton AC, Masteller E, Tang Q, Proctor JM et al. Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and colitis in mice. Nature 2007; 449: 361-365.
56. Feil R, Brocard J, Mascrez B, LeMeur M, Metzger D, Chambon P. Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci USA 1996; 93: 10887-10890.
57. Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol 2002; 2: 465-475.
58. Gorelik L, Gilbride K, Dobles M, Kalled SL, Zandman D, Scott ML. Normal B cell homeostasis requires B cell activation factor production by radiation-resistant cells. J Exp Med 2003; 198: 937-945.
59. Leng L, Metz CN, Fang Y, Xu J, Donnelly S, Baugh J et al. MIF signal transduction initiated by binding to CD74. J Exp Med 2003; 197: 1467-1476.
60. Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L et al. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene 2007; 26: 5046-5059.
61. Starlets D, Gore Y, Binsky I, Haran M, Harpaz N, Shvidel L et al. Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival. Blood 2006; 107: 4807-4816.
62. Schiemann B, Gommerman JL, Vora K, Cachero TG, Shulga-Morskaya S, Dobles M et al. An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science 2001; 293: 2111-2114.
63. Fingerle-Rowson G, Petrenko O, Metz CN, Forsthuber TG, Mitchell R, Huss R et al. The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci USA 2003; 100: 9354-9359.
64. Nakano H, Yanagita M, Gunn MD. CD11c(+)B220(+)Gr-1(+) cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J Exp Med 2001; 194: 1171-1178.
65. Asselin-Paturel C, Boonstra A, Dalod M, Durand I, Yessaad N, Dezutter-Dambuyant C et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2001; 2: 1144-1150.
66. Bjorck P. Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice. Blood 2001; 98: 3520-3526.
67. Colonna M, Trinchieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004; 5: 1219-1226.
68. Asselin-Paturel C, Brizard G, Pin JJ, Briere F, Trinchieri G. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol 2003; 171: 6466-6477.
69. Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through Toll-like receptor 9. Blood 2004; 103: 1433-1437.
70. Blasius AL, Giurisato E, Cella M, Schreiber RD, Shaw AS, Colonna M. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol 2006; 177: 3260-3265.
71. Krug A, French AR, Barchet W, Fischer JA, Dzionek A, Pingel JT et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004; 21: 107-119.
72. Barchet W, Krug A, Cella M, Newby C, Fischer JA, Dzionek A et al. Dendritic cells respond to influenza virus through TLR7- and PKR-independent pathways. Eur J Immunol 2005; 35: 236-242.
73. Blasius AL, Colonna M. Sampling and signaling in plasmacytoid dendritic cells: the potential roles of Siglec-H. Trends Immunol 2006; 27: 255-260.
74. O'Keeffe M, Hochrein H, Vremec D, Caminschi I, Miller JL, Anders EM et al. Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus. J Exp Med 2002; 196: 1307-1319.
75. Kamath AT, Henri S, Battye F, Tough DF, Shortman K. Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 2002; 100: 1734-1741.
76. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999; 5: 919-923.
77. Yoneyama H, Matsuno K, Zhang Y, Nishiwaki T, Kitabatake M, Ueha S et al. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol 2004; 16: 915-928.
78. Colonna M. TLR pathways and IFN-regulatory factors: to each its own. Eur J Immunol 2007; 37: 306-309.
79. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004; 303: 1526-1529.
80. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004; 303: 1529-1531.
81. Lund J, Sato A, Akira S, Medzhitov R, Iwasaki A. Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 2003; 198: 513-520.
82. Akira S. TLR signaling. Curr Top Microbiol Immunol 2006; 311: 1-16.
83. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004; 5: 987-995.
84. Honda K, Taniguchi T. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 2006; 6: 644-658.
85. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses. Nature 2005; 434: 772-777.
86. Le Bon A, Tough DF. Links between innate and adaptive immunity via type I interferon. Curr Opin Immunol 2002; 14: 432-436.
87. Yoneyama H, Matsuno K, Toda E, Nishiwaki T, Matsuo N, Nakano A et al. Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J Exp Med 2005; 202: 425-435.
88. Grouard G, Rissoan MC, Filgueira L, Durand I, Banchereau J, Liu YJ. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J Exp Med 1997; 185: 1101-1111.
89. Fiebiger E, Meraner P, Weber E, Fang IF, Stingl G, Ploegh H et al. Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J Exp Med 2001; 193: 881-892.
90. Krug A, Veeraswamy R, Pekosz A, Kanagawa O, Unanue ER, Colonna M et al. Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells. J Exp Med 2003; 197: 899-906.
91. + T cells: a new role for plasmacytoid dendritic cells in adaptive immunity. Blood 2003; 101: 3520-3526.
92. Dalod M, Hamilton T, Salomon R, Salazar-Mather TP, Henry SC, Hamilton JD et al. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J Exp Med 2003; 197: 885-898.
93. Boonstra A, Asselin-Paturel C, Gilliet M, Crain C, Trinchieri G, Liu YJ et al. Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: dependency on antigen dose and differential toll-like receptor ligation. J Exp Med 2003; 197: 101-109.
94. Salio M, Palmowski MJ, Atzberger A, Hermans IF, Cerundolo V. CpG-matured murine plasmacytoid dendritic cells are capable of in vivo priming of functional CD8 T cell responses to endogenous but not exogenous antigens. J Exp Med 2004; 199: 567-579.
95. + T-cell responses in vivo after viral stimulation. Blood 2004; 104: 1808-1815.
96. Colonna M, Cella M. Crosspresentation: plasmacytoid dendritic cells are in the business. Immunity 2007; 27: 419-421.